Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma Interventions: Drug: Daratumumab Injection; Drug: Dexamethasone Oral; Drug: Lenalidomide Pill; Drug: Bortezomib Injection Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Janssen Scientific Affairs, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials